Age‐related common miRNA polymorphism associated with severe toxicity in lung cancer patients treated with platinum‐based chemotherapy

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1681|44|S1|21-29

ISSN： 0305-1870

Source： CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol.44, Iss.S1, 2017-12, pp. : 21-29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platinum-Based, Leukocyte-Depleting Chemotherapy Does Not Alter Induced Sputum Markers of Neutrophilic Inflammation in COPD Patients with Unresectable Non-Small Cell Lung Cancer

By  

Respiration, Vol. 70, Iss. 2, 2003-05 ,pp. : 166-171

Karger

Access to resources Recommend Favorite

An ERCC4 regulatory variant predicts grade‐3 or ‐4 toxicities in patients with advanced non‐small cell lung cancer treated by platinum‐based therapy

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 6, 2018-03 ,pp. : 1218-1229

John Wiley & Sons Inc

Access to resources Recommend Favorite

Role of DNA Repair Gene Polymorphisms in the Efficiency of Platinum-Based Adjuvant Chemotherapy for Non-Small Cell Lung Cancer

By Mathiaux Juliette   >  

Molecular Diagnosis & Therapy, Vol. 15, Iss. 3, 2011-06 ,pp. : 159-166

Adis International

Access to resources Recommend Favorite

Non-Platinum-Based First-Line Followed by Platinum-Based Second-Line Chemotherapy or the Reverse Sequence in Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Analysis by the Lung Cancer Group of the Hellenic Oncology Research Group

By  

Oncology, Vol. 78, Iss. 3-4, 2010-06 ,pp. : 229-236

Karger

Access to resources Recommend Favorite

A Retrospective Comparison of Docetaxel and Paclitaxel for Patients with Advanced or Recurrent Esophageal Cancer Who Previously Received Platinum-Based Chemotherapy

By  

Oncology, Vol. 81, Iss. 3-4, 2011-11 ,pp. : 237-242

Karger

Access to resources Recommend Favorite